PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739697
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1739697
Cardiovascular Monitoring And Diagnostic Devices Market is estimated to be valued at USD 3,627.7 Mn in 2025 and is expected to reach USD 7,437.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 3,627.7 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 10.80% | 2032 Value Projection: | USD 7,437.2 Mn |
Cardiac monitoring generally refers to the continuous or intermittent monitoring of cardiac activity, usually by electrocardiography, to assess the patient's condition in relation to the heart rhythm which included are ECG monitoring devices, Holter monitoring devices, ECG stress test devices and event monitoring devices. Cardiovascular system monitoring and diagnostic devices are used for continuous monitoring of heart patients suffering from various cardiovascular diseases. Cardiac monitoring usually means continuous or intermittent cardiac monitoring, usually by electrocardiography, to assess the patient's condition in relation to the heart rhythm. An electrocardiogram (ECG) is a device that records the electrical activity of the heart as waveforms with electrodes placed in contact with the body (chest) and the signals recorded on an electrocardiogram screen. Cardiac monitor is a way to check the electrical activity of the heart to make sure it is working normally. Five small stickers called electrodes will be attached to body. They are connected to either a small box (telemetry box) or a large wall-mounted monitor.
Increasing mergers and acquisitions by key market players, and increasing number of funding are expected to drive the global cardiovascular monitoring and diagnostic devices market's growth. For instance, on October 14, 2021 Cardiolyse, a U.K.-based e-health care company, announced crowd funding campaign on the Aescuvest platform, European digital venture capital platform in the healthcare space. Through Aescuvest every individual can invest in Cardiolyse and cloud ECG & HRV analysis platform that enables real-time remote monitoring of heart health and provides simple, personalized, and data-driven reports to identify risks up to two months in advance.